Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
RLAY
#1750
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+14.77%
Monthly Change
+21.42%
6 month change
+185.79%
Cambio anual
+213.76%
Cierres anteriores
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
Volumen
219
Markets
Acciones
Atención Sanitaria
RLAY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Noticias
Relay Therapeutics stock hits 52-week high at 9.64 USD
【決算速報】リレー セラピューティクス、売上高は予想を上回り、利益は予想を上回る結果に
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
FDAのブレークスルー指定後、Relay Therapeuticsの決算に注目集まる
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech 2025年度決算:利益660%急増も2026年は慎重見通し
Relay earnings in focus as FDA breakthrough fuels optimism
リレー・セラピューティクスの株価上昇、FDAが画期的治療薬指定を付与
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
リレー社の乳がん薬、FDAからブレークスルー治療指定を獲得
FDA grants breakthrough therapy status to Relay’s breast cancer drug